A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.
about
Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing ManagementF-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic reviewCurrent approaches and challenges for monitoring treatment response in colon and rectal cancerThe use of (18)F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patientsDecision analysis for the cost-effective management of recurrent colorectal cancerPET scanning in malignancy: infant, adolescent or mature citizen?Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.Value of Surveillance (18)F-FDG PET/CT in Colorectal Cancer: Comparison with Conventional Imaging Studies.Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study.FDG-PET in colorectal cancer.Correlation of tissue biopsy and fine needle aspiration cytology with positron emission tomography results.18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.Restaging of colorectal cancer and PET/CT.In colorectal liver metastases, the presence of extrahepatic disease correlates with the pathology of the primary tumour.(18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancerThe Use of PET-CT in the Assessment of Patients with Colorectal Carcinoma.Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options.Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer.FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEACombined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer.Update of PET and PET/CT for hepatobiliary and pancreatic malignancies.The role of positron emission tomography in colorectal carcinoma.The Clinical Meaning of Benign Colon Uptake in (18)F-FDG PET: Comparison with Colonoscopic Findings.Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis.Routine use of positron-emission tomography/computed tomography for staging of primary colorectal cancer: does it affect clinical management?Surveillance of patients following surgery with curative intent for colorectal cancer.Detection of resectable recurrences in colorectal cancer patients with 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomographyA comparison of positron emission tomography and colonoscopy for the detection of advanced colorectal neoplasms in subjects undergoing a health check-up.Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging.The Preoperative Assessment of Hepatic Tumours: Evaluation of UK Regional Multidisciplinary Team Performance.Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers.Late sacral recurrence of rectal cancer treated by heavy ion radiotherapy: a case report.The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterizationMeta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.Integrated FDG PET/CT: Utility and Applications in Clinical Oncology."Vanishing liver metastases"-A real challenge for liver surgeons.
P2860
Q26743853-4F98BF4C-DD9A-40C2-90FA-A8B28A6A9093Q26830033-2004F7DA-71F4-45FD-8C15-EBF3D927D7BAQ27010257-A59BF4B6-2BF1-49ED-9420-1CCEA16E00AFQ27300759-A4302212-BBEC-498B-887E-2EB194917A8FQ27853168-3F7AA1DF-6915-466F-92A5-A5DAF8282CD2Q28354061-606C208E-918B-46EE-824E-6BB1F26CC0DFQ28354070-5E25603B-7021-4B97-878A-826FDE6F4410Q33550577-81757885-645A-4E7E-BB97-BBDB677DE95AQ33704530-D79833C9-E3E3-4E77-A131-D7C83E501684Q33780787-F91FA49A-C422-4548-9D1B-F86599FE1661Q34051953-65631756-B7B2-451A-9497-728CB81EF69FQ34572647-8AA7172B-EEBA-49E5-B524-E2D79EAF355DQ34954095-BC499170-2C25-47BF-9150-5F67BC9DD09AQ35127213-0BC3EEB4-2BAD-4724-8AC7-7A1B48E84BD6Q35233507-05D14B08-7975-4B96-88EA-460A3158E434Q35379752-583C7B42-6A87-43B4-8EC8-CBB55F45BB69Q35615772-3C51BFAD-FE55-4A30-8C6E-7FC4DEAF28B3Q35687578-F758308D-EAD8-4C0A-B35D-D418004741BDQ35697582-A93DCA8D-3BEF-4ABD-B5EB-A16C4D9406CFQ35760705-8168CFA0-C177-4A5B-8488-66B999C52209Q35760809-84A9B8B2-F5FF-4F77-BBC6-2C570C5E2FAAQ35850832-9354F4C9-0C69-4A07-8954-027770CD4EE0Q35928605-5E382E38-EE81-4658-9799-040721449567Q36066047-D6617356-0E5B-424C-B92E-B1C63B57D2A0Q36101799-A0BC303C-2E42-45A0-A78D-91462085A3CCQ36107454-F51F963E-FF3D-49BB-AC43-528FAAD0E497Q36598926-B4F53DD5-7DCA-4C6B-BA56-CE1D80647F7CQ36689709-1873B81F-758D-4471-A443-F53766C683E8Q36893811-4F772112-1494-4D07-951A-C217BB2D08CFQ37025733-4F20B848-8C85-4B6B-902D-DEBE8291BA79Q37028132-EE781220-AFD1-4B1C-8BC7-BE281CA317B8Q37034524-48C9AD0E-59C8-4F66-AA5C-064B8B2F356AQ37154790-8FD7FDE2-826A-4E2C-8FFD-6D412DE64238Q37255453-4B83E36F-007B-4B18-BA53-4DB7653FC63EQ37324867-50BFEFA4-3F29-4DF2-BFCE-C1BACDB4CC25Q37328589-F5C4DBE7-F0D2-4C7D-AA90-14D1AFB2E7E4Q37440346-2F276752-FEF4-45C9-BA56-8761408AD883Q37591301-484621FD-8580-4C8E-A1DD-A9636741A158Q38260852-7BB676C6-51BA-429C-BCFE-BDBAFDD2A040Q38267816-59310635-0C90-46E7-84C3-3353453DFF04
P2860
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A meta-analysis of the literat ...... f recurrent colorectal cancer.
@ast
A meta-analysis of the literat ...... f recurrent colorectal cancer.
@en
type
label
A meta-analysis of the literat ...... f recurrent colorectal cancer.
@ast
A meta-analysis of the literat ...... f recurrent colorectal cancer.
@en
prefLabel
A meta-analysis of the literat ...... f recurrent colorectal cancer.
@ast
A meta-analysis of the literat ...... f recurrent colorectal cancer.
@en
P2093
P1476
A meta-analysis of the literat ...... f recurrent colorectal cancer.
@en
P2093
Gambhir SS
Huebner RH
Schwimmer J
Shepherd JE
P304
P407
P577
2000-07-01T00:00:00Z